Evidence map›Paper›PMID 41505235›Full record

ArticleJournal of the American Chemical Society2026

Chemical Synthesis of Native ADP-Ribosylated Oligonucleotides Enables Analysis of DNA ADP-Ribosylation Hydrolase Specificity.

Li Tang, Yang Lu, Femke L A M van der Heijden, Yanrong Chen, Shuyan Jiang, Nico J Meeuwenoord, Lingxiao Liu, Zongxing Yu, Zhenrong Chen, Marion Schuller and 3 more

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Li TangCarbohydrate-Based Drug Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Yang LuSir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, U.K.
Femke L A M van der HeijdenBio-Organic Synthesis, Leiden Institute of Chemistry, Leiden University, Leiden 2300 RA, The Netherlands.
Yanrong ChenZhongshan Institute for Drug Discovery, Zhongshan 528400, China.
Shuyan JiangZhongshan Institute for Drug Discovery, Zhongshan 528400, China.
Nico J MeeuwenoordBio-Organic Synthesis, Leiden Institute of Chemistry, Leiden University, Leiden 2300 RA, The Netherlands.
Lingxiao LiuZhongshan Institute for Drug Discovery, Zhongshan 528400, China.
Zongxing YuZhongshan Institute for Drug Discovery, Zhongshan 528400, China.
Zhenrong ChenCarbohydrate-Based Drug Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Marion SchullerSir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, U.K.
Dmitri V FilippovBio-Organic Synthesis, Leiden Institute of Chemistry, Leiden University, Leiden 2300 RA, The Netherlands.
Ivan AhelSir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, U.K.
Qiang LiuCarbohydrate-Based Drug Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.ORCID 0000-0003-1229-7908

Funding

Wellcome Trust
6 · The paper itself

Abstract

ADP-ribosylation (ADPr) is a modification by which an ADP-ribose moiety is conjugated to different molecules by ADP-ribosyltransferases (ARTs) to control various cellular processes in organisms from all kingdoms of life. While traditionally considered primarily as a post-translational modification of proteins, recent evidence has demonstrated that ADPr of nucleic acids (DNA and RNA) has emerged as a widespread type of ADPr. However, the precise biological roles and underlying mechanisms remain elusive, largely due to the lack of ADP-ribosylated nucleic acid molecular tools. Inspired by the native thymidine modification sites of ADP-ribosylated DNA, we developed a synthetic method for the chemo- and stereoselective assembly of both anomers of ADP-ribosylated thymidine (T-ADPr). We further tailored our method to successfully synthesize ADP-ribosylated oligonucleotides with desired sequences via an automatic solid-phase synthesis. We used the synthetic ADPr substrates, including the ADP-ribosylated DNA sequence motif TCTC that is targeted by bacterial ARTs to control DNA replication or antiphage response, and showed the utility of newly developed tools to characterize the specificity and mechanism of action of different hydrolases in ADPr reversal.

Indexed as

Adenosine Diphosphate RiboseDNAOligonucleotidesADP-RibosylationN-Glycosyl HydrolasesSubstrate SpecificityAdenosine Diphosphate RiboseADP-ribosylarginine hydrolaseDNAN-Glycosyl HydrolasesOligonucleotides

Identifiers

PMID41505235
PMCPMC12879935

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.